These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23846201)

  • 1. Is the use of topical antibiotics for intravitreal injections the standard of care or are we better off without antibiotics?
    Chen RW; Rachitskaya A; Scott IU; Flynn HW
    JAMA Ophthalmol; 2013 Jul; 131(7):840-2. PubMed ID: 23846201
    [No Abstract]   [Full Text] [Related]  

  • 2. Reducing the risk of endophthalmitis after intravitreous injection.
    Kim SJ; Chomsky AS; Sternberg P
    JAMA Ophthalmol; 2013 May; 131(5):674-5. PubMed ID: 23699844
    [No Abstract]   [Full Text] [Related]  

  • 3. Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics.
    Hsu J; Gerstenblith AT; Garg SJ; Vander JF
    Am J Ophthalmol; 2014 Mar; 157(3):514-8.e1. PubMed ID: 24332373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask.
    Shimada H; Hattori T; Mori R; Nakashizuka H; Fujita K; Yuzawa M
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1885-90. PubMed ID: 23389553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection.
    Storey P; Dollin M; Rayess N; Pitcher J; Reddy S; Vander J; Hsu J; Garg S;
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):235-42. PubMed ID: 25940556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics.
    Bhavsar AR; Stockdale CR; Ferris FL; Brucker AJ; Bressler NM; Glassman AR;
    Arch Ophthalmol; 2012 Jun; 130(6):809-10. PubMed ID: 22801859
    [No Abstract]   [Full Text] [Related]  

  • 7. No increase in incidence of post-intravitreal injection endophthalmitis without topical antibiotics: a prospective study.
    Tanaka K; Shimada H; Mori R; Nakashizuka H; Hattori T; Okubo Y
    Jpn J Ophthalmol; 2019 Sep; 63(5):396-401. PubMed ID: 31446502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting.
    Brynskov T; Kemp H; Sørensen TL
    Retina; 2014 May; 34(5):951-7. PubMed ID: 24317292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.
    Cheung CS; Wong AW; Lui A; Kertes PJ; Devenyi RG; Lam WC
    Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical antibiotics to reduce the risk of endophthalmitis after intravitreal injection?
    Ziemssen F; Bartz-Schmidt KU
    Arch Ophthalmol; 2010 Sep; 128(9):1222-3; author reply 1223-4. PubMed ID: 20837814
    [No Abstract]   [Full Text] [Related]  

  • 11. Prophylaxis for endophthalmitis following intravitreal injection: antisepsis and antibiotics.
    Wykoff CC; Flynn HW; Rosenfeld PJ
    Am J Ophthalmol; 2011 Nov; 152(5):717-9.e2. PubMed ID: 22017840
    [No Abstract]   [Full Text] [Related]  

  • 12. Endophthalmitis is not a "never event".
    Schachat AP; Rosenfeld PJ; Liesegang TJ; Stewart MW
    Ophthalmology; 2012 Aug; 119(8):1507-8. PubMed ID: 22858024
    [No Abstract]   [Full Text] [Related]  

  • 13. Antisepsis with polyhexanide is effective against endophthalmitis after intravitreal injections.
    Ristau T; Kirchhof B; Fauser S
    Acta Ophthalmol; 2014 Sep; 92(6):e494-6. PubMed ID: 24460667
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravitreal injections: a review of the evidence for best practice.
    Fagan XJ; Al-Qureshi S
    Clin Exp Ophthalmol; 2013 Jul; 41(5):500-7. PubMed ID: 23078366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National survey of the ophthalmic use of anti-vascular endothelial growth factor drugs in Israel.
    Waisbourd M; Goldstein M; Loewenstein A
    Isr Med Assoc J; 2011 Mar; 13(3):141-6. PubMed ID: 21608333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eliminating antibiotic prophylaxis for intravitreal injections: a consecutive series of 18,839 injections by a single surgeon.
    Bhavsar AR; Sandler DR
    Retina; 2015 Apr; 35(4):783-8. PubMed ID: 25526099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
    Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. POOLED ESTIMATES OF INCIDENCE OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS WITH AND WITHOUT TOPICAL ANTIBIOTIC PROPHYLAXIS.
    Reibaldi M; Pulvirenti A; Avitabile T; Bonfiglio V; Russo A; Mariotti C; Bucolo C; Mastropasqua R; Parisi G; Longo A
    Retina; 2018 Jan; 38(1):1-11. PubMed ID: 28267115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection.
    Mason JO; White MF; Feist RM; Thomley ML; Albert MA; Persaud TO; Yunker JJ; Vail RS
    Retina; 2008 Apr; 28(4):564-7. PubMed ID: 18398358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suspected bacterial endophthalmitis following intravitreal anti-VEGF injection: case series and literature review.
    Hoevenaars NE; Gans D; Missotten T; van Rooij J; Lesaffre E; van Meurs JC
    Ophthalmologica; 2012; 228(3):143-7. PubMed ID: 22796790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.